4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-002527
Chief Executive Officer acquired 62,815 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Robinson Chandler · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-28 | Other acquisition : show line 1 in the form | +62,815 | 62,815 | I |
Loading xslF345X05/rdgdoc.xml…